Literature DB >> 247990

Decreased activity of peptide-elongation factors after treatment with cholesterol esterase.

J Hradec, Z Tuhácková, Z Dusek.   

Abstract

1. Peptide-elongation factors were purified from rat liver and treated with cholesterol esterase and phospholipase A2 immobilized on Sepharose 4B. 2. Binding of L-[3H]-phenylalanyl-tRNA to 40S ribosomal subunits was decreased by approx. 70% and to polyribosomes by 30% in the presence of the binding factor incubated with cholesterol esterase. Treatment of this factor with immobilized phospholipase A2 decreased the binding to smaller ribosomal subunits by only about 15%. 3. Poly(U)-dependent phenylalanine polymerization by ribosomal subunits was decreased to approx. 30% of its original value by treatment of both elongation factors with cholesterol esterase. 4. The normal activity of esterase-treated elongation factor in both the binding reaction and peptide-elongation assay was fully recovered by the addition of cholesteryl 14-methyl-hexadecanoate. 5. Different classes of lipids present in peptide-elongation factor 1 have apparently different functions. Whereas phospholipids are required to maintain the strcture of heavy aggregates of this factor, the presence of cholesteryl 14-methylhexadecanoate is obviously necessary for the normal function of peptide-elongation factors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 247990      PMCID: PMC1185655          DOI: 10.1042/bj1720009

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

Review 1.  The role of cholesteryl 14-methylhexadecanoate in gene expression and its significance for cancer.

Authors:  J Hradec
Journal:  Prog Biochem Pharmacol       Date:  1975

2.  Elongation factors from human lymphatic tissue: Isolation and some properties.

Authors:  E Bermek; H Matthaei
Journal:  FEBS Lett       Date:  1970-09-24       Impact factor: 4.124

3.  Purification and properties of rabbit reticulocyte elongation factor 1.

Authors:  W M Kemper; W C Merrick; B Redfield; C K Liu; H Weissbach
Journal:  Arch Biochem Biophys       Date:  1976-06       Impact factor: 4.013

Review 4.  Separation of large quantities of eukaryotic ribosomal subunits by zonal ultracentrifugation.

Authors:  C C Sherton; R F Di Camelli; I G Wool
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

Review 5.  Involvement of phospholipids in the multiple forms of eukaryotic elongation factor 1.

Authors:  A B Legocki; H Weissbach
Journal:  Acta Biol Med Ger       Date:  1974

6.  Multiple forms of elongation factor 1 from calf brain.

Authors:  H M Moon; B Redfield; S Millard; F Vane; H Weissbach
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  Interactions of the heavy and light forms of elongation factor I with guanine nucleotides and aminoacyl-tRNA.

Authors:  A B Legocki; B Redfield; H Weissbach
Journal:  Arch Biochem Biophys       Date:  1974-04-02       Impact factor: 4.013

8.  Effect of cholesteryl 14-methylhexadecanoate on the activity of some amino acid-transfer ribonucleic acid ligases from mammalian tissues.

Authors:  J Hradec; Z Dusek
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

9.  Intermediate reactions in the binding of aminoacyl-transfer ribonucleic acid to rat liver ribosomes. the interaction of cholesteryl 14-methylhexadecanoate.

Authors:  J Hradec
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

10.  The chemical constitution of carcinolipin.

Authors:  J Hradec; L Dolejs
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

View more
  3 in total

1.  Cholesteryl esters are bound by a peptide-initiation and a peptide-elongation factor.

Authors:  Z Tuhácková; J Hradec
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

2.  Purification and some properties of a protein factor binding and deacylating initiator transfer ribonucleic acid.

Authors:  P Pohlreich; O Kríz; Z Tuhácková; Z Dusek; J Hradec
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

3.  Heparin-sepharose 4B at low temperatures retains ribosomes.

Authors:  J Hradec; O Kríz
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.